9 results on '"Hoorntje JC"'
Search Results
2. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy.
- Author
-
van der Schaaf RJ, Timmer JR, Ottervanger JP, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F, and Dambrink JH
- Subjects
- Female, Heart Failure etiology, Heart Failure mortality, Humans, Male, Middle Aged, Multivariate Analysis, Myocardial Infarction mortality, Thrombolytic Therapy methods, Ventricular Dysfunction, Left etiology, Ventricular Dysfunction, Left mortality, Ventricular Dysfunction, Left therapy, Myocardial Infarction therapy, Myocardial Reperfusion methods
- Abstract
Objectives: To investigate the long-term impact of multivessel coronary artery disease (MVD) on cause-specific mortality in patients with ST elevation myocardial infarction (STEMI) treated with reperfusion therapy., Methods and Results: Patients with STEMI (n = 395) treated with primary angioplasty or thrombolysis in the setting of a randomised clinical trial were enrolled in the study. Follow up was 8 (2) years. For patients who died all available records were reviewed to assess the specific cause of death. MVD was present in 57% of patients. Patients with MVD were older and more of them had diabetes and previous myocardial infarction. Compared with the non-MVD group, residual left ventricular ejection fraction was lower (45.9% v 49.6%, p = 0.001) and total mortality was higher in patients with MVD (32% v 19%, p = 0.002). After adjustment for potential confounders this association was not significant (hazard ratio 1.4, 95% confidence interval (CI) 0.9 to 2.2). When the specific cause of death was considered, sudden death was comparable between patients with and without MVD (10% v 8%, p = 0.49) but death caused by heart failure was significantly higher in patients with MVD (hazard ratio 7.4, 95% CI 1.7 to 32.2)., Conclusion: Patients with STEMI and MVD have a higher long-term mortality than do patients with non-MVD. MVD is not an independent predictor of long-term total mortality or sudden death. However, MVD is a very strong and independent predictor of long-term death caused by heart failure.
- Published
- 2006
- Full Text
- View/download PDF
3. Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count.
- Author
-
Smit JJ, Ottervanger JP, Slingerland RJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink AT, de Boer MJ, and van 't Hof AW
- Subjects
- Acute Disease, Aged, Biomarkers, Coronary Angiography, Electrocardiography, Female, Humans, Male, Middle Aged, Myocardial Infarction diagnosis, Myocardial Reperfusion Injury diagnosis, Myocardial Reperfusion Injury immunology, Predictive Value of Tests, Prognosis, Treatment Outcome, Leukocyte Count, Myocardial Infarction immunology, Myocardial Infarction therapy, Myocardial Reperfusion adverse effects
- Abstract
Background: Elevated white blood cell (WBC) count on admission in patients with ST segment elevation myocardial infarction (STEMI) has been associated with an adverse prognosis. Whether successful reperfusion by primary percutaneous coronary intervention (PCI) is associated with a decrease in WBC count is unknown., Methods: In this subanalysis of the On-TIME trial, WBC count was measured on admission and 6 h and 24 h after primary PCI for STEMI (n = 364). Angiographic measurements of reperfusion, including TIMI-flow and myocardial blush grade, were compared with changes in WBC count., Results: Restoration of TIMI 3 flow by primary PCI was associated with a significant decrease in median WBC count (11.5 (9.7-14.2), 10.7 (9.0-12.5), 9.9 (8.5-11.5) at baseline, 6 h and 24 h), whereas after unsuccessful PCI (TIMI < 3 flow) WBC count remained elevated (12.5 (9.5-14.6), 12.1 (9.9-14.4), and 11.4 (9.2-15.2)). Improved myocardial blush was also related to a decrease in WBC count. After multivariate analysis, improved myocardial perfusion (TIMI 3 flow and myocardial blush grade 3) was an independent predictor of a decrease of WBC count after PCI., Conclusion: Impaired myocardial reperfusion after primary PCI for STEMI is associated with persistent WBC elevation.
- Published
- 2006
- Full Text
- View/download PDF
4. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.
- Author
-
De Luca G, van 't Hof AW, de Boer MJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, Zijlstra F, and Suryapranata H
- Subjects
- Aged, Angioplasty, Balloon mortality, Confounding Factors, Epidemiologic, Female, Humans, Male, Myocardial Infarction mortality, Myocardial Infarction pathology, Myocardial Reperfusion mortality, Salvage Therapy mortality, Survival Analysis, Thrombolytic Therapy mortality, Time Factors, Treatment Outcome, Angioplasty, Balloon methods, Myocardial Infarction therapy, Myocardial Reperfusion methods
- Abstract
Aims: The prognostic role of time-to-treatment in primary angioplasty is still a matter of debate. The aim of our study was to evaluate the relationship between time-to-treatment and myocardial perfusion in patients with ST-segment-elevation myocardial infarction (STEMI) treated by primary angioplasty., Methods and Results: Our study population consisted of 1072 patients with STEMI treated by primary angioplasty from 1997 to 2001. Myocardial perfusion was evaluated by using ST-segment resolution and myocardial blush grade. Time-to-treatment was defined as the time from symptom-onset to the first balloon inflation. Time-to-treatment was significantly associated with the extent of ST-segment resolution, myocardial blush grade, enzymatic infarct size, and 1-year mortality. After adjustment for baseline confounding factors, time-to-treatment was still associated with impaired ST-segment resolution (adjusted OR [95% CI]=1.01 [1.01-1.02], p<0.001) and myocardial blush (adjusted OR [95% CI]=1.01 [1.01-1.02], p<0.0001)., Conclusions: This study shows that in patients with STEMI treated by primary angioplasty prolonged ischaemic time is associated with impaired myocardial perfusion, larger infarct size, and higher 1-year mortality. Therefore, all efforts should be made to shorten ischaemic time as much as possible to achieve better myocardial perfusion and myocardial salvage in primary angioplasty for STEMI.
- Published
- 2004
- Full Text
- View/download PDF
5. Long-term, cause-specific mortality after myocardial infarction in diabetes.
- Author
-
Timmer JR, Ottervanger JP, Thomas K, Hoorntje JC, de Boer MJ, Suryapranata H, and Zijlstra F
- Subjects
- Angioplasty, Balloon, Coronary mortality, Diabetic Angiopathies drug therapy, Female, Fibrinolytic Agents administration & dosage, Follow-Up Studies, Humans, Infusions, Intravenous, Male, Middle Aged, Multivariate Analysis, Myocardial Infarction drug therapy, Streptokinase administration & dosage, Survival Analysis, Diabetic Angiopathies mortality, Myocardial Infarction mortality, Myocardial Reperfusion mortality
- Abstract
Aims: To compare long-term, cause-specific mortality after reperfusion therapy for ST segment elevation myocardial infarction (STEMI) in patients with and without diabetes., Methods and Results: Patients with STEMI (n = 395) were randomised to intravenous streptokinase (SK) or primary percutaneous coronary intervention (PCI). Median follow-up was 7.5 years (interquartile range 5.6-8.5). A total of 74 patients (19%) had diabetes. Reduced left ventricular ejection fraction (<40%) after STEMI was more often observed in patients with diabetes (27% vs. 15%, P = 0.02). Patients with diabetes had a higher total mortality compared to patients without diabetes (HR 2.4; P < 0.001). Multivariate analysis confirmed that diabetes was an independent risk factor for long-term mortality (HR 2.3; P < 0.001). The incidence of sudden death was comparable in both patient groups (HR 1.6; P = 0.23). The increased mortality in patients with diabetes was mainly caused by heart failure (HR 3.1; P = 0.004). In patients with diabetes, primary PCI was associated with an improved prognosis., Conclusions: Despite reperfusion therapy, STEMI patients with diabetes have an increased long-term mortality. This is due to death by heart failure and not by an increase in sudden death. Primary PCI is associated with an improved prognosis, particularly in patients with diabetes.
- Published
- 2004
- Full Text
- View/download PDF
6. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade.
- Author
-
Henriques JP, Zijlstra F, van 't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC, and Suryapranata H
- Subjects
- Angioplasty, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction mortality, Survival Rate, Treatment Outcome, Coronary Angiography, Myocardial Infarction diagnostic imaging, Myocardial Infarction surgery, Myocardial Reperfusion
- Abstract
Background: Angiographic successful reperfusion in acute myocardial infarction has been defined as TIMI 3 flow. However, TIMI 3 flow does not always result in effective myocardial reperfusion. Myocardial blush grade (MBG) is an angiographic measure of myocardial perfusion. We hypothesized that optimal angiographic reperfusion is defined by TIMI 3 flow and MBG 2 or 3., Methods and Results: In 924 consecutive patients with TIMI 3 flow after angioplasty for acute myocardial infarction, we prospectively studied the value of MBG. End points were death, MACE, enzymatic infarct size, and residual left ventricular ejection fraction. Follow-up was 16+/-11 months. Of the 924 patients, 101 (11%) patients had MBG 0 or 1. Mortality was significantly higher in patients with MBG 0 or 1 compared with patients with MBG 2 or 3 (relative risk, 4.7; 95% CI, 2.3 to 9.5; P<0.001). The combined incidence of MACE was higher in patients with MBG 0 or 1 compared with patients with MBG 2 or 3 (relative risk, 1.8; 95% CI, 1.1 to 2.8; P=0.009). Enzymatic infarct size was larger (1437+/-2388 versus 809+/-1672, P=0.001) and left ventricular ejection fraction was lower (37.7+/-10.6 versus 43.8+/-11.1, P<0.001) in patients with MBG 0 or 1 compared with patients with MBG 2 or 3., Conclusions: MBG is a strong angiographic predictor of mortality in patients with TIMI 3 flow after primary angioplasty. Enzymatic infarct size is larger and residual left ventricular ejection fraction is lower in patients with MBG 0 or 1 compared with MBG 2 or 3. Angiographic definition of successful reperfusion should include both TIMI 3 flow as well as MBG 2 or 3.
- Published
- 2003
- Full Text
- View/download PDF
7. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.
- Author
-
van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, and Zijlstra F
- Subjects
- Aged, Coronary Circulation, Electrocardiography, Female, Humans, L-Lactate Dehydrogenase analysis, Male, Middle Aged, Myocardial Infarction mortality, Myocardium enzymology, Myocardium pathology, Predictive Value of Tests, Prognosis, Stroke Volume, Ventricular Function, Left, Angioplasty, Coronary Angiography methods, Myocardial Infarction diagnosis, Myocardial Infarction therapy, Myocardial Reperfusion
- Abstract
Background: The primary objective of reperfusion therapies for acute myocardial infarction is not only restoration of blood flow in the epicardial coronary artery but also complete and sustained reperfusion of the infarcted part of the myocardium., Methods and Results: We studied 777 patients who underwent primary coronary angioplasty during a 6-year period and investigated the value of angiographic evidence of myocardial reperfusion (myocardial blush grade) in relation to the extent of ST-segment elevation resolution, enzymatic infarct size, left ventricular function, and long-term mortality. The myocardial blush immediately after the angioplasty procedure was graded by two experienced investigators, who were otherwise blinded to all clinical data: 0, no myocardial blush; 1, minimal myocardial blush; 2, moderate myocardial blush; and 3, normal myocardial blush. The myocardial blush was related to the extent of the early ST-segment elevation resolution on the 12-lead ECG. Patients with blush grades 3, 2, and 0/1 had enzymatic infarct sizes of 757, 1143, and 1623 (P<0.0001), respectively, and ejection fractions of 50%, 46%, and 39%, respectively (P<0.0001). After a mean+/-SD follow-up of 1.9+/-1.7 years, mortality rates of patients with myocardial blush grades 3, 2, and 0/1 were 3%, 6%, and 23% (P<0.0001), respectively. Multivariate analysis showed that the myocardial blush grade was a predictor of long-term mortality, independent of Killip class, Thrombolysis In Myocardial Infarction grade flow, left ventricular ejection fraction (LVEF), and other clinical variables., Conclusions: In patients after reperfusion therapy, the myocardial blush grade as seen on the coronary angiogram can be used to describe the effectiveness of myocardial reperfusion and is an independent predictor of long-term mortality.
- Published
- 1998
- Full Text
- View/download PDF
8. Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction.
- Author
-
van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, and Zijlstra F
- Subjects
- Aged, Analysis of Variance, Chi-Square Distribution, Female, Humans, Logistic Models, Male, Myocardial Infarction complications, Myocardial Infarction mortality, Stroke Volume, Time Factors, Treatment Outcome, Ventricular Function, Left, Angioplasty, Balloon, Coronary, Myocardial Infarction therapy, Myocardial Reperfusion methods
- Abstract
Background: Reperfusion therapy by primary coronary angioplasty has been shown to be beneficial for patients who present themselves up to 12 h after the onset of symptoms. However, the relationship between outcome and ischaemic time for patients who present relatively late after the onset of symptoms is still uncertain. The aim of this study was to investigate differences in patient characteristics, left ventricular function and clinical outcome among early (< 3 h), intermediate (3-6 h) and late (6-24 h) treated patients., Methods and Results: From August 1990 until December 1995, we studied 496 patients who underwent primary coronary angioplasty for acute myocardial infarction. Patients who underwent reperfusion therapy between 6 and 24 h were more often of female gender and more often had diabetes. Primary coronary angioplasty was less successful with later time to reperfusion. Patients who had reperfusion therapy within 6 h showed recovery of left ventricular function at 6 months follow-up, while the left ventricular function of patients treated late had deteriorated. Reocclusion of the infarct-related vessel at follow-up coronary angiography was highest for patients with an ischaemic time of more than 6 h. They more often suffered a repeat myocardial infarction and had a significantly higher 6 months mortality. After adjustment for age, heart rate at presentation, gender, and the presence of diabetes by multi-variate analysis, ischaemic time remained an independent predictor of both left ventricular function recovery and 6 month mortality., Conclusions: The time from symptom onset to reperfusion is related to some baseline clinical characteristics, procedural success rate, left ventricular function and clinical outcome.
- Published
- 1998
- Full Text
- View/download PDF
9. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.
- Author
-
Zijlstra F, de Boer MJ, Beukema WP, Liem AL, Reiffers S, Huysmans D, Hoorntje JC, Suryapranata H, and Simoons ML
- Subjects
- Aged, Costs and Cost Analysis, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction mortality, Myocardial Infarction physiopathology, Recurrence, Stroke Volume, Survival Rate, Treatment Outcome, Ventricular Function, Left, Angioplasty, Balloon, Coronary economics, Fibrinolytic Agents therapeutic use, Myocardial Infarction drug therapy, Myocardial Infarction therapy, Myocardial Reperfusion economics, Streptokinase therapeutic use, Thrombolytic Therapy economics
- Abstract
The comparative efficacy of thrombolytic drugs and primary angioplasty for acute myocardial infarction have recently been studied, but long-term follow-up data have not yet been reported. We conducted a randomized trial involving 301 patients with acute myocardial infarction; 152 patients were randomized to primary angioplasty and 149 to intravenous streptokinase. Left ventricular function was assessed with a radionuclide technique both at hospital discharge and at the end of the follow-up period. Follow-up data were collected after a mean (+/-SD) of 31 +/- 9 months. Total medical costs were calculated. At the end of the follow-up period, 5% of the angioplasty patients had died from a cardiac cause compared to 11% of the patients randomized to intravenous streptokinase, P = 0.031. Cardiac death or a non-fatal reinfarction occurred in 7% of angioplasty patients compared to 28% of streptokinase patients, P < 0.001. There was a sustained benefit of angioplasty compared to streptokinase on left ventricular function. The total medical costs in the two groups were similar. Coronary anatomy (patency and single or multivessel disease), infarct location and previous myocardial infarction were important determinants of clinical outcome and costs. After 31 +/- 9 months of follow-up, primary angioplasty compared to intravenous streptokinase results in a lower rate of cardiac death and reinfarction, a better left ventricular ejection fraction, and no increase in total medical costs.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.